• 1
    Fioretos T, Strombeck B, Sandberg T, et al. Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. Blood 1999;94:225232.
  • 2
    Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, et al. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer 2012;118:28792888.
  • 3
    Visconte V, Tabarroki A, Zhang L, et al. Molecular Characterization Of Myeloid Neoplasms Harboring Isochromosome 17q Abnormality. Blood 2013;122:2596.
  • 4
    Rogers HJ, Visconte V, Tabarroki A, et al. Myeloid neoplasms with isochromosome 17q [i(17q)] share myelodysplastic/myeloproliferative features, poor prognosis and high risk of leukemic transformation related to mutational overlap of SETBP1, SRSF1, CSF3R and TP53 genes. Mod Pathol 2014;27(Suppl 2):374A.
  • 5
    McClure RF, Dewald GW, Hoyer JD, et al. Isolated isochromosome 17q: A distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course. Br J Haematol 1999;106:445454.
  • 6
    Pinheiro RF, Chauffaille Mde L, Silva MR. Isochromosome 17q in MDS: A marker of a distinct entity. Cancer Genet Cytogenet 2006;166:189190.